Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Lenvatinib, tislelizumab, gemcitabine and cisplatin
DRUG
2 trials
Sponsors
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions
Advanced Cholangiocarcinoma
Phase 2
Lenvatinib, Tislelizumab Plus Gemcitabine and Cisplatin (GPLET) in Patients with Advanced Cholangiocarcinoma
Recruiting
NCT05532059
Second Affiliated Hospital, School of Medicine, Zhejiang University
Advanced Cholangiocarcinoma
Start: 2022-01-31
End: 2028-08-31
Target: 100
Updated: 2025-02-10
Phase 3
Lenvatinib, Tislelizumab Combined with Gemcitabine and Cisplatin (GPLET) in the Treatment of Advanced Cholangiocarcinoma
Recruiting
NCT05823311
Second Affiliated Hospital, School of Medicine, Zhejiang University
Advanced Cholangiocarcinoma
Start: 2023-09-01
End: 2027-12-31
Target: 80
Updated: 2025-02-10